IDEXX Laboratories, Inc. vs Stitch Fix Inc — how do they compare? IDEXX Laboratories, Inc. trades at $571 (market cap $46.22B), while Stitch Fix Inc trades at $3.79 (market cap $497.68M). The key difference: IDEXX Laboratories, Inc. is far larger — about 92.9× Stitch Fix Inc's market cap. Which is the better fit depends on your goals.
| IDXX | SFIX | |
|---|---|---|
Market Cap | $46.22B | $497.68M |
Sector | Health | Consumer Cyclical |
52-Week High | $766.68 | $5.83 |
52-Week Low | $526.44 | $3.06 |
Enterprise Value | $47.12B | $385.40M |
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $570.58, down 4.23% over 24 hours, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $4.27 surpassing the $3.94 expectation. Revenue growth remains robust, supported by a 74.21% ROE and expanding diagnostic offerings. Recent news highlights product expansion, including a dual-species cardiac test, reinforcing its market leadership in veterinary diagnostics.
The outlook is positive, driven by durable competitive advantages and international growth potential. However, elevated valuation multiples and competitive pressures pose risks. Analyst consensus is bullish with a $683.33 price target, suggesting significant upside from current levels, though investors should monitor execution on guidance and macroeconomic headwinds.
Stitch Fix (SFIX) trades at $3.54, down 10.83% over 24 hours, reflecting recent market pressure. The stock shows a bullish technical signal with key moving averages supporting an uptrend, while oscillators remain neutral. Fundamentally, revenue stabilized at $1.27B in 2025, with net losses narrowing significantly to -$28.74M, indicating progress toward profitability. Recent news highlights AI-driven personalization tools and exclusive brand collaborations as growth catalysts.
The outlook suggests a potential rebound opportunity, supported by a consensus price target of $4.75 (34% upside). However, risks include persistent net losses, competitive pressures in retail, and sensitivity to consumer spending trends. Analyst sentiment is mixed, with 27% buy ratings but 64% hold, signaling cautious optimism amid the company's turnaround efforts.
Trailing returns across standard periods
Latest headlines on both assets
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →